Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-35,775
Closed -$13.5M 1629
2026
Q1
$13.5M Buy
+35,775
New +$15.3M 0.11% 171
2025
Q3
Sell
-9,681
Closed -$4.71M 1583
2025
Q2
$4.71M Buy
9,681
+5,448
+129% +$3.1M 0.04% 445
2025
Q1
$2.6M Buy
+4,233
New +$2.41M 0.03% 611
2024
Q4
Sell
-2,132
Closed -$1.28M 1589
2024
Q3
$1.28M Sell
2,132
-7,158
-77% -$4.06M 0.01% 898
2024
Q2
$5.04M Buy
+9,290
New +$5.32M 0.03% 399
2024
Q1
Sell
-514
Closed -$301K 1535
2023
Q4
$301K Buy
+514
New +$288K ﹤0.01% 1181
2022
Q3
Sell
-5,197
Closed -$2.44M 1926
2022
Q2
$2.44M Buy
5,197
+1,901
+58% +$927K 0.03% 697
2022
Q1
$1.67M Buy
+3,296
New +$1.58M 0.02% 870
2021
Q3
Sell
-2,436
Closed -$1.16M 2168
2021
Q2
$1.16M Buy
2,436
+82
+3% +$39.4K 0.01% 929
2021
Q1
$1.08M Buy
+2,354
New +$1.15M 0.02% 872
2020
Q4
Sell
-719
Closed -$345K 2003
2020
Q3
$345K Buy
+719
New +$353K 0.01% 1208
2019
Q3
Sell
-860
Closed -$310K 1357
2019
Q2
$310K Buy
+860
New +$287K 0.01% 677

Other funds holding CHE

Michael Gelband's CHE Position: Q2 2026 in Review

Michael Gelband sold out of Chemed (CHE) in Q2 2026, closing a stake of 35,775 shares — an estimated $13.5M sold.

Michael Gelband first reported a position in CHE in Q2 2019 and held it in 12 quarters. The position peaked at $13.5M in Q1 2026. 528 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Michael Gelband reported no remaining Chemed position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 35,775 Chemed shares in Q2 2026, an estimated $13.5M.
  • Michael Gelband first reported a position in Chemed in Q2 2019 and held it in 12 quarters.
  • Michael Gelband's Chemed position peaked at $13.5M in Q1 2026.
  • 528 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.